PD-1 antibody
Clinical trials for PD-1 antibody explained in plain language.
Never miss a new study
Get alerted when new PD-1 antibody trials appear
Sign up with your email to follow new studies for PD-1 antibody, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Chemotherapy plus immunotherapy tested against rare EBV-Driven immune storm
Disease control CompletedResearchers are testing a combination of L-DEP chemotherapy (aspargase, liposomal doxorubicin, etoposide, and methylprednisolone) and a PD-1 antibody as initial treatment for people with Epstein-Barr virus-positive lymphoma-associated hemophagocytic lymphohistiocytosis, a rare an…
Matched conditions: PD-1 ANTIBODY
Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for bile duct cancer: triple therapy shows promise after chemo fails
Disease control CompletedThis Phase 2 trial tested a combination of three treatments—local chemotherapy delivered via beads into the liver, a targeted drug called apatinib, and an immunotherapy (PD-1 antibody)—in 20 patients with advanced bile duct cancer that had worsened after standard first-line chemo…
Matched conditions: PD-1 ANTIBODY
Phase 2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC